Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Fulgent Genetics, Inc.FLGT · Entity 2545 | Director | August 01, 2022 | August 03, 2022 |
| Tintri, Inc.TNTR · Entity 165007 | Director | June 29, 2017 | June 29, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Fulgent Genetics, Inc.
Report date August 01, 2022 · Filed August 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,100 |
Reported balance
After 2022-08-01 transaction · row 1
1 source rowRow 1 · 2022-08-01 · Grant · Acquired 1,600 · Balance 5,100 F1: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
Tintri, Inc.
Report date June 29, 2017 · Filed June 29, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,166 |
Reported balance
Holding disclosure · report date 2017-06-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,166 F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 3/8 of the RSU's vest on the closing of the Issuer's initial public offering and an additional 1/8 of the RSU's shall vest on the 15th day of the following months of September, December, March and June. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.68 · Expires 2025-12-07 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2017-06-29 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: 1/48 of the shares subject to the option vested on January 8, 2016 and an additional 1/48 of the shares vest monthly thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 3/8 of the RSU's vest on the closing of the Issuer's initial public offering and an additional 1/8 of the RSU's shall vest on the 15th day of the following months of September, December, March and June.
F2: 1/48 of the shares subject to the option vested on January 8, 2016 and an additional 1/48 of the shares vest monthly thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2022 Filed Aug 3, 2022 21:39 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044287 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,100 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 313 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0001209191-22-033477 · doc4.xml · derivative · entry 7 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 313 shares Expires 2029-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 313 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001209191-22-033477 · doc4.xml · derivative · entry 6 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 313 shares Expires 2028-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 500 | $55.25 | $27,625.00 |
DisclosureSEC source: 0001209191-22-033477 · doc4.xml · nonDerivative · entry 5 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 313 | $55.44 | $17,351.22 |
DisclosureSEC source: 0001209191-22-033477 · doc4.xml · nonDerivative · entry 4 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 313 | $5.81 | $1,818.47 |
DisclosureSEC source: 0001209191-22-033477 · doc4.xml · nonDerivative · entry 3 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 313 | $55.32 | $17,315.16 |
DisclosureSEC source: 0001209191-22-033477 · doc4.xml · nonDerivative · entry 2 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 313 | $3.93 | $1,228.53 |
DisclosureSEC source: 0001209191-22-033477 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030954 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 625 | $0.00 Strike: $15.82 | $0.00 |
DisclosureSEC source: 0001209191-22-015590 · doc4.xml · derivative · entry 9 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813 Underlying: Common Stock · 625 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 625 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0001209191-22-015590 · doc4.xml · derivative · entry 8 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,563 Underlying: Common Stock · 625 shares Expires 2029-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 625 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001209191-22-015590 · doc4.xml · derivative · entry 7 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313 Underlying: Common Stock · 625 shares Expires 2028-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 625 | $61.27 | $38,292.56 |
DisclosureSEC source: 0001209191-22-015590 · doc4.xml · nonDerivative · entry 6 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 625 | $15.82 | $9,887.50 |
DisclosureSEC source: 0001209191-22-015590 · doc4.xml · nonDerivative · entry 5 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 625 | $61.40 | $38,376.25 |
DisclosureSEC source: 0001209191-22-015590 · doc4.xml · nonDerivative · entry 4 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 625 | $5.81 | $3,631.13 |
DisclosureSEC source: 0001209191-22-015590 · doc4.xml · nonDerivative · entry 3 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 625 | $61.42 | $38,387.63 |
DisclosureSEC source: 0001209191-22-015590 · doc4.xml · nonDerivative · entry 2 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 625 | $3.93 | $2,453.13 |
DisclosureSEC source: 0001209191-22-015590 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 312 | $0.00 Strike: $15.82 | $0.00 |
DisclosureSEC source: 0001209191-21-054292 · doc4.xml · derivative · entry 9 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,438 Underlying: Common Stock · 312 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 312 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0001209191-21-054292 · doc4.xml · derivative · entry 8 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,188 Underlying: Common Stock · 312 shares Expires 2029-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 312 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001209191-21-054292 · doc4.xml · derivative · entry 7 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 938 Underlying: Common Stock · 312 shares Expires 2028-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 312 | $91.44 | $28,529.90 |
DisclosureSEC source: 0001209191-21-054292 · doc4.xml · nonDerivative · entry 6 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 312 | $5.81 | $1,812.66 |
DisclosureSEC source: 0001209191-21-054292 · doc4.xml · nonDerivative · entry 5 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 312 | $91.05 | $28,408.85 |
DisclosureSEC source: 0001209191-21-054292 · doc4.xml · nonDerivative · entry 4 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 312 | $15.82 | $4,935.84 |
DisclosureSEC source: 0001209191-21-054292 · doc4.xml · nonDerivative · entry 3 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 312 | $91.38 | $28,510.75 |
DisclosureSEC source: 0001209191-21-054292 · doc4.xml · nonDerivative · entry 2 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 312 | $3.93 | $1,224.60 |
DisclosureSEC source: 0001209191-21-054292 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 21:25 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 125 | $74.17 | $9,271.25 |
DisclosureSEC source: 0001209191-21-038717 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: The shares were sold in multiple transactions at prices ranging from $74.09 to $74.29, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:41 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,250 | $0.00 Strike: $15.82 | $0.00 |
DisclosureSEC source: 0001209191-21-037821 · doc4.xml · derivative · entry 7 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:41 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 313 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0001209191-21-037821 · doc4.xml · derivative · entry 6 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 313 shares Expires 2029-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:41 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 313 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001209191-21-037821 · doc4.xml · derivative · entry 5 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 313 shares Expires 2028-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:41 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 1,876 | $71.41 | $133,965.54 |
DisclosureSEC source: 0001209191-21-037821 · doc4.xml · nonDerivative · entry 4 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,125 F1 · price: The shares were sold in multiple transactions at prices ranging from $71.2781 to $71.4784, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:41 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 1,250 | $15.82 | $19,775.00 |
DisclosureSEC source: 0001209191-21-037821 · doc4.xml · nonDerivative · entry 3 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:41 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 313 | $5.81 | $1,818.53 |
DisclosureSEC source: 0001209191-21-037821 · doc4.xml · nonDerivative · entry 2 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:41 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 313 | $3.93 | $1,230.09 |
DisclosureSEC source: 0001209191-21-037821 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:25 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035449 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,125 F1 · shares: Reflects an award of restricted stock units relating to 2,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 20, 2021, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:19 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,187 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0001209191-21-019850 · doc4.xml · derivative · entry 5 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813 Underlying: Common Stock · 2,187 shares Expires 2029-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:19 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Options (Right to Buy) · Derivative | 937 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001209191-21-019850 · doc4.xml · derivative · entry 4 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,563 Underlying: Common Stock · 937 shares Expires 2028-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:19 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 3,374 | $101.62 | $342,882.08 |
DisclosureSEC source: 0001209191-21-019850 · doc4.xml · nonDerivative · entry 3 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125 F1 · price: The shares were sold in multiple transactions at prices ranging from $100.5077 to $103.6447, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:19 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 2,187 | $5.81 | $12,706.03 |
DisclosureSEC source: 0001209191-21-019850 · doc4.xml · nonDerivative · entry 2 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:19 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 937 | $3.93 | $3,677.73 |
DisclosureSEC source: 0001209191-21-019850 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 00:48 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,631 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-20-059268 · doc4.xml · derivative · entry 3 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,631 shares Expires 2026-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after April 13, 2016, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 00:48 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 4,269 | $44.24 | $188,876.78 |
DisclosureSEC source: 0001209191-20-059268 · doc4.xml · nonDerivative · entry 2 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 F1 · price: The shares were sold in multiple transactions at prices ranging from $44.16 to $44.3784, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 00:48 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 2,631 | $0.38 | $999.78 |
DisclosureSEC source: 0001209191-20-059268 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 20, 2020 01:09 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,631 | $0.00 Strike: $12.31 | $0.00 |
DisclosureSEC source: 0001209191-20-047657 · doc4.xml · derivative · entry 3 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,631 shares Expires 2026-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The units subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after June 22, 2016, and 1/16th of such units vesting every three months over the remaining 36 months, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| August 17, 2020 Filed Aug 20, 2020 01:09 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 3,914 | $40.87 | $159,967.14 |
DisclosureSEC source: 0001209191-20-047657 · doc4.xml · nonDerivative · entry 2 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,013 F1 · price: The shares were sold in multiple transactions at prices ranging from $40.72 to $41.03, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 17, 2020 Filed Aug 20, 2020 01:09 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionCommon Stock | 2,631 | $12.31 | $32,392.87 |
DisclosureSEC source: 0001209191-20-047657 · doc4.xml · nonDerivative · entry 1 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2020 Filed May 27, 2020 23:48 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $15.82 | $0.00 |
DisclosureSEC source: 0001209191-20-032439 · doc4.xml · derivative · entry 6 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-05-26 F4 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 23:48 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,631 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-20-032439 · doc4.xml · derivative · entry 5 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,631 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after February 23, 2016, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 23:48 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001209191-20-032439 · doc4.xml · derivative · entry 4 BOLGER JOHN C · CIK 0001183863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2028-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.